annual CFI:
-$62.85M-$62.82M(-261766.67%)Summary
- As of today (September 17, 2025), NAMS annual cash flow from investing activities is -$62.85 million, with the most recent change of -$62.82 million (-261766.67%) on December 31, 2024.
- During the last 3 years, NAMS annual CFI has fallen by -$62.82 million (-261766.67%).
- NAMS annual CFI is now -392700.00% below its all-time high of -$16.00 thousand, reached on December 1, 2020.
Performance
NAMS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$159.14M-$161.99M(-5673.94%)Summary
- As of today (September 17, 2025), NAMS quarterly cash flow from investing activities is -$159.14 million, with the most recent change of -$161.99 million (-5673.94%) on June 30, 2025.
- Over the past year, NAMS quarterly CFI has dropped by -$158.93 million (-76041.63%).
- NAMS quarterly CFI is now -5673.94% below its all-time high of $2.85 million, reached on March 31, 2025.
Performance
NAMS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$218.53M-$158.93M(-266.62%)Summary
- As of today (September 17, 2025), NAMS TTM cash flow from investing activities is -$218.53 million, with the most recent change of -$158.93 million (-266.62%) on June 30, 2025.
- Over the past year, NAMS TTM CFI has dropped by -$217.94 million (-36690.40%).
Performance
NAMS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NAMS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | -10000.0% | -10000.0% |
| 3 y3 years | -10000.0% | -100.0% | -100.0% |
| 5 y5 years | -10000.0% | - | - |
NAMS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -5673.9% | at low | <-9999.0% | at low |
| 5 y | 5-year | <-9999.0% | at low | -5673.9% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | -5673.9% | at low | <-9999.0% | at low |
NAMS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$159.14M(-5673.9%) | -$218.53M(+266.6%) |
| Mar 2025 | - | $2.85M(-104.6%) | -$59.61M(-5.2%) |
| Dec 2024 | -$62.85M(>+9900.0%) | -$62.18M(>+9900.0%) | -$62.85M(+9294.3%) |
| Sep 2024 | - | -$75.00K(-64.1%) | -$669.00K(+12.6%) |
| Jun 2024 | - | -$209.00K(-45.7%) | -$594.00K(+54.3%) |
| Mar 2024 | - | -$385.00K(+5400.0%) | -$385.00K(+5400.0%) |
| Dec 2023 | -$24.00K(-89.1%) | - | - |
| Mar 2023 | - | -$7000.00 | -$7000.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$221.00K(+820.8%) | - | - |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | -$24.00K(+50.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | -$16.00K | - | - |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual cash flow from investing activities?
- What is the all time high annual CFI for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual CFI year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly CFI year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM cash flow from investing activities?
- What is the all time high TTM CFI for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM CFI year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual cash flow from investing activities?
The current annual CFI of NAMS is -$62.85M
What is the all time high annual CFI for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual cash flow from investing activities is -$16.00K
What is NewAmsterdam Pharma Company N.V. annual CFI year-on-year change?
Over the past year, NAMS annual cash flow from investing activities has changed by -$62.82M (-261766.67%)
What is NewAmsterdam Pharma Company N.V. quarterly cash flow from investing activities?
The current quarterly CFI of NAMS is -$159.14M
What is the all time high quarterly CFI for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly cash flow from investing activities is $2.85M
What is NewAmsterdam Pharma Company N.V. quarterly CFI year-on-year change?
Over the past year, NAMS quarterly cash flow from investing activities has changed by -$158.93M (-76041.63%)
What is NewAmsterdam Pharma Company N.V. TTM cash flow from investing activities?
The current TTM CFI of NAMS is -$218.53M
What is the all time high TTM CFI for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM cash flow from investing activities is $0.00
What is NewAmsterdam Pharma Company N.V. TTM CFI year-on-year change?
Over the past year, NAMS TTM cash flow from investing activities has changed by -$217.94M (-36690.40%)